2 insider filings
Kristine M Ball, insider filing for ELVN
Show all 2
- 4Insider filing for ELVN
- 3New insider at ELVN
Kristine M Ball, reporting
ELVN
Enliven Therapeutics, Inc. SEC filings
Every EDGAR filing for Enliven Therapeutics, Inc. (ELVN), newest first, with AI summaries and stories.
- Ticker
- ELVN
- CIK
- 1672619
- Sector
- Biotech and pharma
- Latest filing
- 2d
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 7 open-market sales ($1.2M), 3 grants or exercises.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE MAJOR8-KEnliven Therapeutics, Inc.ELVNLIVE Enliven appoints Kristine Ball to board
- Board increased to 8 directors
- Kristine Ball appointed as Class II director
- Annual cash compensation of $45,000 for director role
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE Enliven Therapeutics, Inc. (ELVN) reports insider trading.
- Garland J. Scott sold 13,000 shares on 10/01/2026 at $46.67.
- Garland J. Scott bought 13,000 shares on 10/01/2026 at $15.47.
- Stock option for 13,000 shares expires on 01/07/2036.
J. Scott Garland
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE J. Scott Garland, planned sale of ELVN shares
J. Scott Garland
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE 2 insider filings
Benjamin Hohl, insider filing for ELVN
Show all 2
- 4Insider filing for ELVN
- 4Insider filing for ELVN
Benjamin Hohl, reporting
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE Benjamin Hohl, planned sale of ELVN shares
Benjamin Hohl, reporting
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE Richard A. Heyman, planned sale of ELVN shares
Richard A. Heyman, reporting
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE 2 insider filings
Benjamin Hohl, insider filing for ELVN
Show all 2
- 4Insider filing for ELVN
- 4Insider filing for ELVN
Benjamin Hohl, reporting
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE Mika K Derynck, insider filing for ELVN
Mika K Derynck, reporting
ROUTINESCHEDULE 13G/AEnliven Therapeutics, Inc.ELVNLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
NOTABLE10-QEnliven Therapeutics, Inc.ELVNLIVE ROUTINE8-KEnliven Therapeutics, Inc.ELVNLIVE ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE Mika K Derynck, planned sale of ELVN shares
Mika K Derynck, reporting
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE 2 insider filings
Benjamin Hohl, insider filing for ELVN
Show all 2
- 4Insider filing for ELVN
- 4Insider filing for ELVN
Benjamin Hohl, reporting
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE Helen Louise Collins, planned sale of ELVN shares
Helen Louise Collins, reporting
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE Lori Anne Kunkel, insider filing for ELVN
Lori Anne Kunkel, reporting
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE ORBIMED ADVISORS LLC, insider filing for ELVN
ORBIMED ADVISORS LLC, reporting · OrbiMed Capital GP VII LLC, reporting · +1 more
NOTABLESCHEDULE 13D/AEnliven Therapeutics, Inc.ELVNLIVE Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)
ORBIMED ADVISORS LLC, filed by
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE 3 Form 144 notices
ORBIMED ADVISORS LLC, planned sale of ELVN shares
Show all 3
- 144Planned insider sale of ELVN shares
- 144Planned insider sale of ELVN shares
- 144Planned insider sale of ELVN shares
ORBIMED ADVISORS LLC, reporting
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE 2 insider filings
Benjamin Hohl, insider filing for ELVN
Show all 2
- 4Insider filing for ELVN
- 4Insider filing for ELVN
Benjamin Hohl, reporting
ROUTINESCHEDULE 13G/AEnliven Therapeutics, Inc.ELVNLIVE Ownership stake disclosure by Polar Capital Holdings Plc (amended)
Polar Capital Holdings Plc, filed by
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE ORBIMED ADVISORS LLC, insider filing for ELVN
ORBIMED ADVISORS LLC, reporting · OrbiMed Capital GP VII LLC, reporting · +1 more
NOTABLESCHEDULE 13D/AEnliven Therapeutics, Inc.ELVNLIVE Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)
ORBIMED ADVISORS LLC, filed by
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE Benjamin Hohl, planned sale of ELVN shares
Benjamin Hohl, reporting
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE 3 Form 144 notices
ORBIMED CAPITAL LLC, planned sale of ELVN shares
Show all 3
- 144Planned insider sale of ELVN shares
- 144Planned insider sale of ELVN shares
- 144Planned insider sale of ELVN shares
ORBIMED CAPITAL LLC, reporting
ROUTINE8-KEnliven Therapeutics, Inc.ELVNLIVE ROUTINE424B5Enliven Therapeutics, Inc.ELVNLIVE ROUTINE424B5Enliven Therapeutics, Inc.ELVNLIVE ROUTINE8-KEnliven Therapeutics, Inc.ELVNLIVE ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE Lori Anne Kunkel, insider filing for ELVN
Lori Anne Kunkel, reporting
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE Lori Anne Kunkel, planned sale of ELVN shares
Lori Anne Kunkel, reporting
ROUTINE4Enliven Therapeutics, Inc.ELVNLIVE Helen Louise Collins, insider filing for ELVN
Helen Louise Collins, reporting
ROUTINE144Enliven Therapeutics, Inc.ELVNLIVE Helen Louise Collins, planned sale of ELVN shares
Helen Louise Collins, reporting
ROUTINESCHEDULE 13G/AEnliven Therapeutics, Inc.ELVNLIVE 5 13G filings
Ownership stake disclosure by Polar Capital Holdings Plc (amended)
Show all 5
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Polar Capital Holdings Plc, filed by
ROUTINESCHEDULE 13G/AEnliven Therapeutics, Inc.ELVNLIVE Ownership stake disclosure by Polar Capital Holdings Plc (amended)
Polar Capital Holdings Plc, filed by
NOTABLE10-QEnliven Therapeutics, Inc.ELVNLIVE ROUTINE8-KEnliven Therapeutics, Inc.ELVNLIVE